94 related articles for article (PubMed ID: 155127)
41. Inhibition of plasminogen activation and plasmin activity after euglobulin precipitation and acidification of plasma.
Lauritsen OS
Scand J Clin Lab Invest; 1969 Apr; 23(2):121-8. PubMed ID: 4244675
[No Abstract] [Full Text] [Related]
42. Spectrophotometrical determination of plasminogen and plasmin inhibitors in human plasma using fibrin suspension as a substrate.
Saito Y; Kanai S; Takabayashi K; Inada Y
Thromb Res; 1980 Nov; 20(3):307-13. PubMed ID: 6451951
[No Abstract] [Full Text] [Related]
43. Shortened method for the determination of euglobulin lysis time employing Malayan pit viper venom.
Starr T; Gertler MM
Thromb Res; 1989 Jun; 54(5):511-7. PubMed ID: 2772869
[No Abstract] [Full Text] [Related]
44. C1 inactivator inhibition by plasmin.
Harpel PC
J Clin Invest; 1970 Mar; 49(3):568-75. PubMed ID: 4244455
[TBL] [Abstract][Full Text] [Related]
45. C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis.
Kluft C
Thromb Res; 1978 Aug; 13(2):135-51. PubMed ID: 694838
[No Abstract] [Full Text] [Related]
46. Nephelometric and immunodiffusion assays for the fourth component of complement in acquired C1 esterase inhibitor deficiency.
Keil LB; DeBari VA
Clin Chem; 1988 Feb; 34(2):427. PubMed ID: 3124983
[No Abstract] [Full Text] [Related]
47. Human monocytes release plasma serine protease inhibitors in vitro.
Kłoczko J; Bielawiec M; Giedrojć J; Radziwon P; Galar M
Haemostasis; 1990; 20(4):229-32. PubMed ID: 1700759
[TBL] [Abstract][Full Text] [Related]
48. [Plasminogen and antiplasmin activity in various disorders. Comparison between the method by affinity chromatography and that with euglobulin fraction (author's transl)].
Matsumoto M
Nihon Ketsueki Gakkai Zasshi; 1974 Dec; 37(6):834-42. PubMed ID: 4283387
[No Abstract] [Full Text] [Related]
49. Effect of urokinase upon euglobulin lysis time and thrombin time.
Lee TK; Huang SC; Lin SA; Chien LM
Taiwan Yi Xue Hui Za Zhi; 1976 Mar; 75(03):190-7. PubMed ID: 1066436
[No Abstract] [Full Text] [Related]
50. [Euglobulin lysis time method (author's transl)].
Kazama M
Rinsho Byori; 1976 Apr; 24(4):316-20. PubMed ID: 132550
[No Abstract] [Full Text] [Related]
51. Inhibition of fibrinolytic activity of plasmin by suramin (antrypol) and trypan blue.
Moroz LA
Thromb Res; 1977 Apr; 10(4):605-11. PubMed ID: 193210
[No Abstract] [Full Text] [Related]
52. Activation of C'1 to C'1 esterase on gel filtration on Sephadex G-200. Studies on normal human serum, euglobulin and hereditary angioneurotic edema serum.
Laurell AB; Siboo R
Acta Pathol Microbiol Scand; 1966; 68(2):230-42. PubMed ID: 5958663
[No Abstract] [Full Text] [Related]
53. Plasma plasmin inhibitors in Duchenne-type progressive muscular dystrophy.
Shomura I; Nagao N; Sawada Y
Biochem Med; 1985 Jun; 33(3):350-61. PubMed ID: 3160343
[TBL] [Abstract][Full Text] [Related]
54. [The interaction of staphylococci with plasmin and its inhibitors].
Zorin NA; Zhabin SG; Vorob'eva ON
Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):6-10. PubMed ID: 8067117
[TBL] [Abstract][Full Text] [Related]
55. Quantitative determination of plasmin: a fibrinogenolytic method.
Vukovich T
Clin Chim Acta; 1977 Sep; 79(2):285-90. PubMed ID: 142589
[TBL] [Abstract][Full Text] [Related]
56. Plasma protease inhibitor and anaphylatoxin inactivator levels in chronic urticaria/angioedema and in patients experiencing anaphylactoid reactions to radiographic contrast media.
Mathews KP; Pan PM; Amendola MA; Lewis FH
Int Arch Allergy Appl Immunol; 1986; 79(2):220-3. PubMed ID: 3943918
[TBL] [Abstract][Full Text] [Related]
57. Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate s-2251.
Mussoni L; Raczka E; Chmielewska J; Donati MB; Latallo ZS
Thromb Res; 1979; 15(3-4):341-9. PubMed ID: 158845
[No Abstract] [Full Text] [Related]
58. SUPPLEMENTARY NOTE ON THE EUGLOBULIN FRACTION METHOD AS TOOL OF CLINICAL PLASMIN RESEARCH.
MAKI M
Tohoku J Exp Med; 1963 Nov; 81():179-87. PubMed ID: 14083617
[No Abstract] [Full Text] [Related]
59. Localization and distribution of fibrinolysis inhibition in the walls of human arteries and veins.
Hegt VN
Thromb Res; 1977 Jan; 10(1):121-33. PubMed ID: 139705
[No Abstract] [Full Text] [Related]
60. On the proteolytic inhibitory effect of human foetal and neoplastic tissues.
Fornasari PM; Pandolfi M; Astedt B
Thromb Res; 1976 Jun; 8(6):829-36. PubMed ID: 134463
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
